Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	131.12	186.73	125.74	123.67	117.36	33.01
Short-Term Investments	337.6	154.89	111.61	203.24	188.45	100.01
Cash & Short-Term Investments	468.72	341.62	237.36	326.9	305.81	133.02
Cash Growth	46.13%	43.93%	-27.39%	6.90%	129.90%	3.23%
Accounts Receivable	-	10	0.01	1.57	2.43	6.76
Other Receivables	2.67	0.33	0.04	3.77	1.4	0.74
Receivables	2.67	10.33	0.05	5.33	3.82	7.5
Prepaid Expenses	5.38	3.63	5.67	8.5	5.97	4.79
Restricted Cash	-	-	-	-	0.01	0.01
Total Current Assets	476.77	355.58	243.08	340.74	315.61	145.31
Property, Plant & Equipment	12.3	2.15	4.63	6.73	6.41	7.72
Long-Term Investments	114.56	-	-	-	2	-
Long-Term Deferred Tax Assets	-	-	-	-	-	1.43
Other Long-Term Assets	0.23	0.23	0.23	0.23	0.45	0.45
Total Assets	603.86	357.95	247.93	347.7	324.47	154.92
Accounts Payable	3.05	0.77	3.64	1.6	3.08	2.79
Accrued Expenses	20.62	19.26	24.54	37.31	18.42	12.24
Current Portion of Leases	0.05	1.14	2.52	2.2	1.46	1.26
Current Unearned Revenue	19.7	-	-	1.6	14.48	17.74
Other Current Liabilities	0.12	0.1	0.48	1.31	2.81	1.38
Total Current Liabilities	44.58	21.27	31.18	44.02	40.24	35.41
Long-Term Debt	-	-	-	-	-	9.79
Long-Term Leases	10.86	-	1.14	3.66	4.5	5.96
Long-Term Unearned Revenue	16.51	-	-	-	-	23.79
Other Long-Term Liabilities	-	-	-	-	0.12	-
Total Liabilities	71.94	21.27	32.32	47.67	44.86	74.95
Common Stock	0	0	-	-	-	-
Additional Paid-In Capital	1,003	952.49	752.72	709.68	563.39	297.85
Retained Earnings	-472.2	-615.71	-536.76	-409.36	-283.81	-217.66
Comprehensive Income & Other	1.34	-0.11	-0.36	-0.3	0.03	-0.22
Total Common Equity	531.92	336.68	215.61	300.02	279.61	79.96
Shareholders' Equity	531.92	336.68	215.61	300.02	279.61	79.96
Total Liabilities & Equity	603.86	357.95	247.93	347.7	324.47	154.92
Total Debt	10.9	1.14	3.66	5.86	5.96	17.01
Net Cash (Debt)	572.38	340.48	233.7	321.04	301.85	116.01
Net Cash Growth	78.35%	45.69%	-27.21%	6.36%	160.20%	-9.97%
Net Cash Per Share	9.00	6.00	4.77	6.93	8.78	4.48
Filing Date Shares Outstanding	59.6	58.27	51.28	48.41	43.81	27.29
Total Common Shares Outstanding	59.52	57.71	49.34	47.84	43.75	27.22
Working Capital	432.19	334.3	211.9	296.72	275.37	109.91
Book Value Per Share	8.94	5.83	4.37	6.27	6.39	2.94
Tangible Book Value	531.92	336.68	215.61	300.02	279.61	79.96
Tangible Book Value Per Share	8.94	5.83	4.37	6.27	6.39	2.94
Machinery	7.63	6.47	5.91	5.18	4.19	3.46
Leasehold Improvements	1.77	0.96	0.91	0.88	0.75	0.86

Source: S&P Capital IQ. Standard template. Financial Sources.